CD8A and neoplasm: Compared to WT mice, the Tbkbp1-KO mice had reduced tumor growth rate and improved survival rate (Fig. 3e, f), coupled with increased frequencies of IFNγ-producing CD8+ effector T cells in the tumor and draining lymph node (Fig. 3g, i).